These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 15300959)
1. Do physicians follow systemic treatment and funding policy guidelines? Clemons M; Enright K; Cesta A; Charbonneau F; Chow E; Warr D; Kee-Cresswell D; Chang J; Yogendran G; Trudeau M; De Angelis C; Cottrell W; Dranitsaris G Can J Clin Pharmacol; 2004; 11(1):e168-78. PubMed ID: 15300959 [TBL] [Abstract][Full Text] [Related]
2. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings. Sneed RC; May WL; Stencel C Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092 [TBL] [Abstract][Full Text] [Related]
3. Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer. Liauw W; Segelov E; Lih A; Dunleavy R; Links M; Ward R BMC Cancer; 2005 Jul; 5():89. PubMed ID: 16048654 [TBL] [Abstract][Full Text] [Related]
4. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy. Clemons MJ; Dranitsaris G; Ooi WS; Yogendran G; Sukovic T; Wong BY; Verma S; Pritchard KI; Trudeau M; Cole DE J Clin Oncol; 2006 Oct; 24(30):4895-900. PubMed ID: 17001071 [TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Migliorati CA; Schubert MM; Peterson DE; Seneda LM Cancer; 2005 Jul; 104(1):83-93. PubMed ID: 15929121 [TBL] [Abstract][Full Text] [Related]
6. [Interventions in the rehabilitation of breast cancer patients--a critical literature review of the state of the art]. Weis J; Domann U Rehabilitation (Stuttg); 2006 Jun; 45(3):129-45. PubMed ID: 16755432 [TBL] [Abstract][Full Text] [Related]
7. Breast and cervical cancer screening: clinicians' views on health plan guidelines and implementation efforts. Zapka JG; Puleo E; Taplin S; Solberg LI; Mouchawar J; Somkin C; Geiger AM; Ulcickas Yood M J Natl Cancer Inst Monogr; 2005; (35):46-54. PubMed ID: 16287885 [TBL] [Abstract][Full Text] [Related]
8. Recommendations for zoledronic acid treatment of patients with bone metastases. Berenson JR Oncologist; 2005 Jan; 10(1):52-62. PubMed ID: 15632252 [TBL] [Abstract][Full Text] [Related]
9. Utilization of palliative radiotherapy for breast cancer patients with bone metastases treated with bisphosphonates-Toronto Sunnybrook Regional Cancer Centre experience. Enright K; Clemons M; Chow E Support Care Cancer; 2004 Jan; 12(1):48-52. PubMed ID: 14577020 [TBL] [Abstract][Full Text] [Related]
10. Duration of bisphosphonate treatment: results of a non-randomised study in patients previously treated with local irradiation for bone metastases from breast cancer. Kouloulias VE; Kouvaris JR; Mystakidou K; Varela MN; Kokakis J; Pistevou-Gombaki K; Balafouta M; Gennatas C; Vlahos LJ Curr Med Res Opin; 2004 Jun; 20(6):819-26. PubMed ID: 15200738 [TBL] [Abstract][Full Text] [Related]
11. [IKARUS Project--incidence of bone events in breast cancer: retrospective analysis of patients in oncological centres in the Czech Republic and Slovakia]. Fínek J; Prausová J; Cmejlová V; Cwiertka K; Svébisová H; Vyzula R; Holánek M; Bodorová M; Slavícek L; Kubecová M; Loukotková L; Neumanová R; Lepeyová K; Lysý M; Smejkal J; Soumarová R; Rysková J; Kalisová K; Machanová J; Bohusová M; Alaksa V; Stresko M; Samanová T; Kůta M; Vanásek J; Vondrácková K; Vargovcíková M; Petera J; Pritzová E; Bednarík O; Hlavácová A; Jancoková I; Szeghöová O; Dammak A; Lesková J; Chroust K; Dusek L Klin Onkol; 2009; 22(4):154-62. PubMed ID: 19731877 [TBL] [Abstract][Full Text] [Related]
12. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of patients with prostate cancer receiving zoledronic acid or pamidronate for prevention of skeletal-related events. Sherer JT; Adamus AT Pharmacotherapy; 2007 Feb; 27(2):207-17. PubMed ID: 17253911 [TBL] [Abstract][Full Text] [Related]
14. Why are physicians not persuaded by scientific evidence? A grounded theory interview study. Sekimoto M; Imanaka Y; Kitano N; Ishizaki T; Takahashi O BMC Health Serv Res; 2006 Jul; 6():92. PubMed ID: 16872522 [TBL] [Abstract][Full Text] [Related]
15. The role of bisphosphonates in breast cancer. Coleman RE Breast; 2004 Dec; 13 Suppl 1():S19-28. PubMed ID: 15585379 [TBL] [Abstract][Full Text] [Related]
16. Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients. Walter C; Al-Nawas B; du Bois A; Buch L; Harter P; Grötz KA Cancer; 2009 Apr; 115(8):1631-7. PubMed ID: 19156913 [TBL] [Abstract][Full Text] [Related]
17. Pre-operative investigations: yield and conformity to national guidelines. Juliana H; Lim TA; Inbasegaran K Med J Malaysia; 2003 Mar; 58(1):5-16. PubMed ID: 14556321 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. Grant BT; Amenedo C; Freeman K; Kraut RA J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600 [TBL] [Abstract][Full Text] [Related]
19. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation. Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115 [TBL] [Abstract][Full Text] [Related]
20. Impact of treatment guidelines and implementation of a quality assurance program on quality of care in endometrial cancer. du Bois A; Strutas D; Buhrmann C; Traut A; Ewald-Riegler N; Kommoss S; Gomez R; Harter P Onkologie; 2009 Sep; 32(8-9):493-8. PubMed ID: 19745593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]